Greenberg Lecture: Cancer Prevention and Control
Needs Statement
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to receive regular updates on recent advances and guidelines in the field of internal medicine. Clinical scenarios will be used to review the current management of common medical conditions, including chronic pain and opioid abuse. Multidisciplinary sessions will also be used to educate learners about human trafficking and the role of physicians in identifying and assisting victims in the community. The overall aim of the series is to advance clinical knowledge, enhance the quality of patient care, and improve treatment outcomes.
Target Audience
Physicians, medical students, fellows, and residents.
Learning Objectives
At the conclusion of the session, the participants should be able to:
- Recognize current inequities in cancer screening and prevention and in cancer outcomes.
- Assess and compare different options for reducing inequities in cancer screening and prevention services.
- Examine the effects of three programs to improve cancer prevention and screening for underserved patients receiving care in a large Federally Qualified Health Center System.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Ethics
- 1.00 Participation
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact cpd@bcm.edu.